We analyzed ALDH3A1 protein expression by immunohistochemical staining and assessed the relationships with the histological grade, tumor stage, and lymph node metastasis in OSCC patients, thereby allowing us to obtain greater clinical insights into ALDH3A1 than previous biological findings, and to leverage its prognostic potential for OSCC. This evidence concerns the gene ALDH3A1 and neoplasm.